Evercore ISI upgrades Procter & Gamble to outperform and lifts price target to $166
Evercore ISI raised its rating on Procter & Gamble (PG) to outperform from in‑line and increased its price target to $166, up from $161. The analyst team highlighted steadier U.S. category volumes, with a 40‑basis‑point sequential gain versus the June quarter, and stronger performance from high‑margin brands such as Olay, Downy and Pantene. The upgrade follows an estimate of about 3% organic sales growth in Q1 FY2027 and an expected 4% growth for the full fiscal year. Shares moved higher after the announcement.
Why it matters
Evercore ISI says the higher target implies roughly a 14% upside from the prior close, which could attract buying interest. The firm also expects the sales‑growth outlook to improve operating leverage, potentially supporting earnings momentum.
Key facts
- 1Evercore ISI upgraded Procter & Gamble to outperform from in‑line. cnbc.com
- 2The price target was raised to $166 from $161. cnbc.com
- 3U.S. category volumes rose 40 basis points sequentially versus the June quarter. cnbc.com
- 4Evercore ISI raised its Q1 FY2027 organic sales growth estimate to approximately 3%. investing.com
- 5The firm expects FY2027 total growth of about 4%. investing.com
- 6Procter & Gamble's market capitalization is $339 billion and its P/E ratio is 22. investing.com
Summary written by AlphAI from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.